{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:19:11Z","timestamp":1762147151910,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.yexcr.2018.09.015","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T20:05:54Z","timestamp":1537473954000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Self-complementary and tyrosine-mutant rAAV vectors enhance transduction in cystic fibrosis bronchial epithelial cells"],"prefix":"10.1016","volume":"372","author":[{"given":"Miqu\u00e9ias","family":"Lopes-Pacheco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil Z.","family":"Kitoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo M.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8961-2959","authenticated-orcid":false,"given":"Hilda","family":"Petrs-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia R.M.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2018.09.015_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphar.2016.00275","article-title":"CFTR modulators: shedding light on precision medicine for cystic fibrosis","volume":"7","author":"Lopes-Pacheco","year":"2016","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR epithelial physiology","volume":"74","author":"Saint-Criq","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.yexcr.2018.09.015_bib3","first-page":"1309746","article-title":"Airway epithelium dysfunction in cystic fibrosis and COPD","author":"De Rose","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.yexcr.2018.09.015_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-0636","article-title":"Lengevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry","volume":"161","author":"MacKenzie","year":"2014","journal-title":"Ann. Inter. Med."},{"key":"10.1016\/j.yexcr.2018.09.015_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1513\/AnnalsATS.201408-393OC","article-title":"A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis","volume":"12","author":"Habib","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.yexcr.2018.09.015_bib6","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S2213-2600(14)70218-8","article-title":"Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)","volume":"2","author":"McKone","year":"2014","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.yexcr.2018.09.015_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(16)30427-1","article-title":"Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study","volume":"5","author":"Konstan","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.yexcr.2018.09.015_bib8","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2018.09.015_bib9","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa1709847","article-title":"Tezacaftor-Ivacaftor in residual-function heterozygotes with cystic fibrosis","volume":"377","author":"Rowe","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2018.09.015_bib10","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","article-title":"European cystic fibrosis society standard of care: best practice guidelines","volume":"13","author":"Smyth","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.yexcr.2018.09.015_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S2213-2600(15)00507-X","article-title":"Treatment of cystic fibrosis in low-income countries","volume":"4","author":"Cohen-Cymberknoh","year":"2016","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.yexcr.2018.09.015_bib12","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201507-1428ED","article-title":"Precision medicine: at what price?","volume":"192","author":"Ferkol","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yexcr.2018.09.015_bib13","doi-asserted-by":"crossref","first-page":"e0119796","DOI":"10.1371\/journal.pone.0119796","article-title":"Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation","volume":"10","author":"Rapino","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2018.09.015_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/cbic.201500620","article-title":"Correctors rescue CFTR mutations in nucleotide-binding domain 1 (NBD1) by modulating proteostasis","volume":"17","author":"Lopes-Pacheco","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.yexcr.2018.09.015_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1183\/13993003.01192-2015","article-title":"Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids","volume":"48","author":"Dekkers","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yexcr.2018.09.015_bib16","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1159\/000475578","article-title":"Combination of correctors rescues CFTR transmembrane-domain mutants by mitigating their interactions with proteostasis","volume":"41","author":"Lopes-Pacheco","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.yexcr.2018.09.015_bib17","first-page":"3","article-title":"Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators","author":"Han","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.yexcr.2018.09.015_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated virus for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexcr.2018.09.015_bib19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/14712598.2017.1347630","article-title":"Adeno-associated v\u00edrus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments","volume":"17","author":"Guggino","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated v\u00edrus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"Biodrugs"},{"key":"10.1016\/j.yexcr.2018.09.015_bib21","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1089\/104303401753153956","article-title":"A phase I study of aerolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease","volume":"12","author":"Aitken","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib22","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/104303402760128577","article-title":"A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies","volume":"13","author":"Wagner","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/104303403322124792","article-title":"Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study","volume":"14","author":"Flotte","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.125.2.509","article-title":"Repeated adeno-associated virus serotype 2 aerosol-medicated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial","volume":"125","author":"Moss","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.yexcr.2018.09.015_bib25","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mt.2009.230","article-title":"Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway","volume":"18","author":"Flotte","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/gt.2017.19","article-title":"Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract","volume":"24","author":"Kurosaki","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mt.2011.287","article-title":"The AAV vector tollkit: poised at the clinical crossroads","volume":"20","author":"Asokan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib29","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1172\/JCI8317","article-title":"Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus","volume":"105","author":"Duan","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2018.09.015_bib30","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1128\/JVI.75.4.1824-1833.2001","article-title":"Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation","volume":"75","author":"Douar","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib31","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/sj.gt.3302564","article-title":"Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation","volume":"12","author":"Denby","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib32","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.mt.6300170","article-title":"A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV capsids and viral second-strand SNA synthesis","volume":"15","author":"Zhong","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib33","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1073\/pnas.0802866105","article-title":"Next generation of adeno-associated virus 2 vectors: point mutations in tyrsosines lead to high-efficient transduction at lower doses","volume":"105","author":"Zhong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2018.09.015_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/mt.2010.234","article-title":"Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina","volume":"19","author":"Petrs-Silva","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1440-1681.12037","article-title":"Comparison of transduction efficiency of tyrosine-mutant AAV serotypes vectors in kidney","volume":"40","author":"Qi","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12967-017-1200-1","article-title":"Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models","volume":"15","author":"Markusic","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexcr.2018.09.015_bib38","doi-asserted-by":"crossref","first-page":"25636","DOI":"10.1074\/jbc.M115.671925","article-title":"Combination of correctors rescue \u0394F508del-CFTR by reducing its association with Hsp40 and Hsp27","volume":"290","author":"Lopes-Pacheco","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2018.09.015_bib39","first-page":"3","article-title":"Thymosin \u03b1-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia","author":"Tomati","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.yexcr.2018.09.015_bib40","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1074\/jbc.M112.420489","article-title":"Transcomplementation by a truncation mutant of cystic fibrosis transmemebrane conductance regulator (CFTR) enhances \u0394F508 processing through a biomolecular interaction","volume":"288","author":"Cebotaru","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2018.09.015_bib41","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1128\/jvi.71.8.6020-6027.1997","article-title":"Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins","volume":"71","author":"Hermanns","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib42","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.1128\/jvi.71.10.7361-7371.1997","article-title":"Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells","volume":"71","author":"Kube","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1074\/jbc.M115.687657","article-title":"Chemical modulation of endocytic sorting augments adeno-associated viral transduction","volume":"291","author":"Berry","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2018.09.015_bib44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1164\/rccm.201505-0914OC","article-title":"rAAV-CFTR\u0394R rescues the cystic fibrosis phenotype in human intestinal organoids and cystic fibrosis mice","volume":"193","author":"Vidovic","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yexcr.2018.09.015_bib45","doi-asserted-by":"crossref","first-page":"e88728","DOI":"10.1172\/jci.insight.88728","article-title":"CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes","volume":"1","author":"Steines","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.yexcr.2018.09.015_bib46","doi-asserted-by":"crossref","first-page":"e1002053","DOI":"10.1371\/journal.ppat.1002053","article-title":"AAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis","volume":"7","author":"Johnson","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2018.09.015_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/humc.2017.067","article-title":"A preclinical study in Rhesus macaques for cystic fibrosis to assess gene transfer and transduction by AAV1 and AAV5 with dual-luciferase reporter system","volume":"28","author":"Guggino","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.yexcr.2018.09.015_bib48","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jpedsurg.2016.02.048","article-title":"Vector serotypes screening for use in ovine perinatal lung gene therapy","volume":"51","author":"McClain","year":"2016","journal-title":"J. Pediatr. Sug"},{"key":"10.1016\/j.yexcr.2018.09.015_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.virol.2011.06.009","article-title":"AAV-6 mediated efficient transduction of mouse lower airways","volume":"417","author":"Li","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.yexcr.2018.09.015_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.resp.2007.09.002","article-title":"Does the use of recombinante AAV2 in pulmonary gene therapy damage lung function?","volume":"160","author":"Lassance","year":"2008","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1159\/000363033","article-title":"Single tyrosine mutation in AAV8 vector capsid enhances gene lung delivery and does not alter lung morphofunction in mice","volume":"34","author":"Martini","year":"2014","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.yexcr.2018.09.015_bib52","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000445646","article-title":"Tyrosine mutation in AAV9 capsid improves gene transfer to the mouse lung","volume":"39","author":"Martini","year":"2016","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.yexcr.2018.09.015_bib53","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/hum.2010.016","article-title":"Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2","volume":"21","author":"Kauss","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/hgtb.2011.229","article-title":"Single tyrosine mutation in AAV8 and AAV9 capsids is insufficient to enhance gene to enhance gene delivery to skeletal muscle and heart","volume":"23","author":"Qiao","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.yexcr.2018.09.015_bib55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/sj.mt.6300355","article-title":"Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose","volume":"16","author":"Wu","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib56","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1167\/iovs.09-3847","article-title":"Self-complementary AAV virus (scAAV) safe and long-term gene transfer on the trabelular meshwork of living rats and monkeys","volume":"51","author":"Buie","year":"2010","journal-title":"Investig. Ophtalmol. Vis. Sci."},{"key":"10.1016\/j.yexcr.2018.09.015_bib57","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.yexcr.2018.09.015_bib58","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1089\/hum.2005.16.1116","article-title":"Spliceosome-mediated RNA trans-splicing with recombinante adeno-associated virus partially restore cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells","volume":"16","author":"Liu","year":"2005","journal-title":"Human. Gene Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/hum.2008.173","article-title":"Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial by AAV6.2-mediated segmental trans-splicing","volume":"20","author":"Song","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yexcr.2018.09.015_bib60","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1073\/pnas.0400459101","article-title":"Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation","volume":"101","author":"Cormet-Boyaka","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2018.09.015_bib61","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1128\/JVI.72.11.8568-8577.1998","article-title":"Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue","volume":"71","author":"Duan","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib62","doi-asserted-by":"crossref","first-page":"16042","DOI":"10.1038\/mtm.2016.42","article-title":"Multilineage transduction of resident lung cells in vivo by AAV2\/8 for \u03b11-antitrypsin gene therapy","volume":"3","author":"Payne","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.yexcr.2018.09.015_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.stem.2014.07.012","article-title":"Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function","volume":"15","author":"Hogan","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2018.09.015_bib64","first-page":"e00357","article-title":"Cell cycle-dependent expression of adeno-associated virus 2 (AAV2) rep in coinfections with herpes simplex virus 1 (HSV-1) gives rise to a mosaic of cells replicating either AAV2 or HSV-1","volume":"91","author":"Frazoso","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib65","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1093\/emboj\/19.16.4351","article-title":"Inhibition of S-phase progression by adeno-associated virus Rep78 is mediated by hypophosphorylayed pRb","volume":"19","author":"Saudan","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2018.09.015_bib66","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1128\/JVI.02953-15","article-title":"Identification and validation of small molecular that enhance recombinant adeno-associated virus transduction following high-throughput screens","volume":"90","author":"Nicolson","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib67","doi-asserted-by":"crossref","first-page":"13035","DOI":"10.1128\/JVI.01826-13","article-title":"Mechanistic insights into the enhancement of adeno-associated virus transduction by proteasome inhibitors","volume":"87","author":"Mitchell","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib68","doi-asserted-by":"crossref","first-page":"9835","DOI":"10.1128\/JVI.72.12.9835-9843.1998","article-title":"Adeno-associated virus type2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression","volume":"72","author":"Mah","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2018.09.015_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2006.04.042","article-title":"Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors","volume":"353","author":"Zhao","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.yexcr.2018.09.015_bib70","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","article-title":"Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo","volume":"10","author":"McCarty","year":"2003","journal-title":"Gene Ther."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718309662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718309662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:15:22Z","timestamp":1762146922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482718309662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0014482718309662"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.09.015","relation":{},"ISSN":["0014-4827"],"issn-type":[{"type":"print","value":"0014-4827"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-complementary and tyrosine-mutant rAAV vectors enhance transduction in cystic fibrosis bronchial epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}